{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:55:03Z","timestamp":1791122103369,"version":"4.1.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T00:00:00Z","timestamp":1749254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T00:00:00Z","timestamp":1749254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Key Laboratory of Viral Pathogenesis and Infection Prevention and Control (Jinan University) Open Fund","award":["(2024VPPC-S09)"],"award-info":[{"award-number":["(2024VPPC-S09)"]}]},{"name":"National Innovation and Entrepreneurship Training Program for Undergraduate","award":["202310559054"],"award-info":[{"award-number":["202310559054"]}]},{"name":"Guangdong College Students\u2019 Scientific and Technological Innovation","award":["CX22446 and CX23304"],"award-info":[{"award-number":["CX22446 and CX23304"]}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2020A1515010817; 2022A1515010313; 2023A1515030271"],"award-info":[{"award-number":["2020A1515010817; 2022A1515010313; 2023A1515030271"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2020A1515010817; 2022A1515010313; 2023A1515030271"],"award-info":[{"award-number":["2020A1515010817; 2022A1515010313; 2023A1515030271"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170220"],"award-info":[{"award-number":["82170220"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biomark Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Diffuse large B-cell lymphoma (DLBCL) is a highly heterogeneous disease with variable clinical and molecular features. Studies have highlighted the significant role of \u03b3\u03b4 T cells in the survival of leukemia patients. However, the heterogeneity of \u03b3\u03b4 T cells and their impact on clinical correlation in the peripheral blood of patients with DLBCL remain unclear.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Method<\/jats:title>\n            <jats:p>Single-cell RNA sequencing (scRNA-seq) was employed on 9 blood samples, sourced from 6 patients with diffuse large B-cell lymphoma (DLBCL) and 3 healthy individuals (HIs), to delineate clinically pertinent \u03b3\u03b4 T cell states and subsets in DLBCL patients. Flow cytometry was then employed to validate the relationship between DLBCL prognosis and \u03b3\u03b4 T cell subsets.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Result<\/jats:title>\n            <jats:p>Our study integrated genetic drivers through consensus clustering, leading to the identification of 6 distinct \u03b3\u03b4 T cell subsets in DLBCL and HIs. These subsets include a na\u00efve \u03b3\u03b4 T cell subset characterized by TCF7 and LEF1 expression, a memory \u03b3\u03b4 T cell subset sharing common genes such as GZMK, IL7R, an anti-tumor \u03b3\u03b4 T cell subset with overexpression of IFNG, TNF, and CD69, and two subsets exhibiting TIGIT overexpression indicative of an exhausted \u03b3\u03b4 T cell phenotype. Additionally, a cytotoxic \u03b3\u03b4 T cell subset marked by increased NKG7 and GZMB levels was identified. Our results revealed that while \u03b3\u03b4 T cells possess anti-tumor capacities, their functional effectiveness is diminished due to differentiation into exhausted subpopulations. Several clusters with high cytotoxicity scores also showed elevated exhaustion scores (C13-\u03b3\u03b4-TIGIT.1, C14-\u03b3\u03b4-TIGIT.2), suggesting the presence of a population in DLBCL samples that is simultaneously exhausted and cytotoxic. In particular, the TIGIT.2 \u03b3\u03b4 T cell subset manifests a more pronounced exhaustion score relative to TIGIT.1 \u03b3\u03b4 T cell subset, indicating differential levels of cellular exhaustion among these groups. Our analysis reveals a significant correlation between high expression of TIGIT \u03b3\u03b4 T cell subsets and poorer patient prognoses. We also discovered unique expression profiles within these subgroups: TIGIT.1 \u03b3\u03b4 T cells are marked by elevated CXCR4 expression, contrasting with the TIGIT.2 \u03b3\u03b4 T cell subgroup which exhibits increased CX3CR1 expression. Pseudotime analysis implies a potential differentiation trajectory from na\u00efve and GZMK \u03b3\u03b4 T cells to various terminally differentiated subsets, with genes associated with stemness (e.g., TCF-1) subsequently downregulated. These findings suggest that TIGIT.2 subset may be further along in the differentiation trajectory, potentially representing a more terminally differentiated state than TIGIT.1 subset. According to our clinical validation cohort, the TIGIT<jats:sup>+<\/jats:sup> \u03b3\u03b4 T cell subset is highly expressed in patients and correlates with poor prognosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>We identified genetic subtypes of \u03b3\u03b4 T cells with distinct genotypic and clinical characteristics in DLBCL patients. Expression levels within these subgroups emerged as potential indicators for patient outcomes and as crucial factors in shaping therapeutic strategies. These insights significantly advance our understanding of intricate relationships among cellular subgroups and their roles in influencing disease progression and patient prognosis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40364-025-00795-x","type":"journal-article","created":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T14:02:53Z","timestamp":1749304973000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Heterogeneous characteristics of \u03b3\u03b4 T cells in peripheral blood of diffuse large B-cell lymphoma"],"prefix":"10.1186","volume":"13","author":[{"given":"Peng-Lin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-pu","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Mian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Fang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Nan","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Zhuang","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Yi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Li","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,7]]},"reference":[{"issue":"Suppl 5","key":"795_CR1","doi-asserted-by":"publisher","first-page":"v116","DOI":"10.1093\/annonc\/mdv304","volume":"26","author":"H Tilly","year":"2015","unstructured":"Tilly H, Gomes da Silva M, Vitolo U, Jack A, Meignan M, Lopez-Guillermo A, et al. Diffuse large B-cell lymphoma (DLBCL): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Annals Oncology: Official J Eur Soc Med Oncol. 2015;26(Suppl 5):v116\u201325.","journal-title":"Annals Oncology: Official J Eur Soc Med Oncol"},{"issue":"5","key":"795_CR2","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1200\/JCO.2016.69.3564","volume":"35","author":"RU Trappe","year":"2017","unstructured":"Trappe RU, Dierickx D, Zimmermann H, Morschhauser F, Mollee P, Zaucha JM, et al. Response to rituximab induction is a predictive marker in B-Cell Post-Transplant lymphoproliferative disorder and allows successful stratification into rituximab or R-CHOP consolidation in an international, prospective, multicenter phase II trial. J Clin Oncology: Official J Am Soc Clin Oncol. 2017;35(5):536\u201343.","journal-title":"J Clin Oncology: Official J Am Soc Clin Oncol"},{"issue":"3","key":"795_CR3","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/s41571-022-00722-1","volume":"20","author":"S Mensurado","year":"2023","unstructured":"Mensurado S, Blanco-Dom\u00ednguez R, Silva-Santos B. The emerging roles of \u03b3\u03b4 T cells in cancer immunotherapy. Nat Reviews Clin Oncol. 2023;20(3):178\u201391.","journal-title":"Nat Reviews Clin Oncol"},{"issue":"7","key":"795_CR4","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41568-019-0153-5","volume":"19","author":"B Silva-Santos","year":"2019","unstructured":"Silva-Santos B, Mensurado S, Coffelt SB. \u03b3\u03b4 T cells: pleiotropic immune effectors with therapeutic potential in cancer. Nat Rev Cancer. 2019;19(7):392\u2013404.","journal-title":"Nat Rev Cancer"},{"issue":"24","key":"795_CR5","doi-asserted-by":"publisher","first-page":"11906","DOI":"10.1073\/pnas.1818488116","volume":"116","author":"G Pizzolato","year":"2019","unstructured":"Pizzolato G, Kaminski H, Tosolini M, Franchini DM, Pont F, Martins F, et al. Single-cell RNA sequencing unveils the shared and the distinct cytotoxic hallmarks of human TCRV\u03b41 and TCRV\u03b42 \u03b3\u03b4 T lymphocytes. Proc Natl Acad Sci USA. 2019;116(24):11906\u201315.","journal-title":"Proc Natl Acad Sci USA"},{"key":"795_CR6","doi-asserted-by":"crossref","unstructured":"Cerapio JP, Perrier M, Pont F, Tosolini M, Laurent C, Bertani S et al. Single-Cell RNAseq profiling of human \u03b3\u03b4 T lymphocytes in Virus-Related cancers and COVID-19 disease. Viruses. 2021;13(11).","DOI":"10.3390\/v13112212"},{"issue":"4","key":"795_CR7","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41423-021-00656-1","volume":"18","author":"Y Hu","year":"2021","unstructured":"Hu Y, Fang K, Wang Y, Lu N, Sun H, Zhang C. Single-cell analysis reveals the origins and intrahepatic development of liver-resident IFN-\u03b3-producing \u03b3\u03b4 T cells. Cell Mol Immunol. 2021;18(4):954\u201368.","journal-title":"Cell Mol Immunol"},{"issue":"4","key":"795_CR8","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41577-020-00452-4","volume":"21","author":"JC Ribot","year":"2021","unstructured":"Ribot JC, Lopes N, Silva-Santos B. \u03b3\u03b4 T cells in tissue physiology and surveillance. Nat Rev Immunol. 2021;21(4):221\u201332.","journal-title":"Nat Rev Immunol"},{"issue":"23","key":"795_CR9","doi-asserted-by":"publisher","first-page":"5795","DOI":"10.1158\/1078-0432.CCR-16-0597","volume":"22","author":"AR Almeida","year":"2016","unstructured":"Almeida AR, Correia DV, Fernandes-Platzgummer A, da Silva CL, da Silva MG, Anjos DR, et al. Delta one T cells for immunotherapy of chronic lymphocytic leukemia: Clinical-Grade expansion\/differentiation and preclinical proof of concept. Clin Cancer Res. 2016;22(23):5795\u2013804.","journal-title":"Clin Cancer Res"},{"key":"795_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3389\/fimmu.2023.1202950","volume":"14","author":"A Kent","year":"2023","unstructured":"Kent A, Crump LS, Davila E. Beyond \u03b1\u03b2 T cells: NK, iNKT, and \u03b3\u03b4T cell biology in leukemic patients and potential for off-the-shelf adoptive cell therapies for AML. Front Immunol. 2023;14:27.","journal-title":"Front Immunol"},{"issue":"4","key":"795_CR11","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/j.1365-2567.2009.03162.x","volume":"128","author":"AA K\u00fchl","year":"2009","unstructured":"K\u00fchl AA, Pawlowski NN, Grollich K, Blessenohl M, Westermann J, Zeitz M, et al. Human peripheral gammadelta T cells possess regulatory potential. Immunology. 2009;128(4):580\u20138.","journal-title":"Immunology"},{"issue":"2","key":"795_CR12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10238-022-00817-0","volume":"23","author":"D Qiu","year":"2023","unstructured":"Qiu D, Liu X, Wang W, Jiang X, Wu X, Zheng J, et al. TIGIT axis: novel immune checkpoints in anti-leukemia immunity. Clin Experimental Med. 2023;23(2):165\u201374.","journal-title":"Clin Experimental Med"},{"key":"795_CR13","doi-asserted-by":"publisher","first-page":"4612952","DOI":"10.1155\/2020\/4612952","volume":"2020","author":"Z Jin","year":"2020","unstructured":"Jin Z, Ye W, Lan T, Zhao Y, Liu X, Chen J, et al. Characteristic of TIGIT and DNAM-1 expression on Foxp3\u2009+\u2009\u03b3\u03b4 T cells in AML patients. Biomed Res Int. 2020;2020:4612952.","journal-title":"Biomed Res Int"},{"issue":"11","key":"795_CR14","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41577-019-0221-9","volume":"19","author":"CU Blank","year":"2019","unstructured":"Blank CU, Haining WN, Held W, Hogan PG, Kallies A, Lugli E, et al. Defining \u2018T cell exhaustion\u2019. Nat Rev Immunol. 2019;19(11):665\u201374.","journal-title":"Nat Rev Immunol"},{"key":"795_CR15","doi-asserted-by":"publisher","first-page":"216675","DOI":"10.1016\/j.canlet.2024.216675","volume":"586","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Zuo C, Li Y, Liu L, Yang B, Xia J, et al. Single-cell characterization of infiltrating T cells identifies novel targets for gallbladder cancer immunotherapy. Cancer Lett. 2024;586:216675.","journal-title":"Cancer Lett"},{"key":"795_CR16","doi-asserted-by":"publisher","first-page":"217018","DOI":"10.1016\/j.canlet.2024.217018","volume":"596","author":"J Yuan","year":"2024","unstructured":"Yuan J, Zhang J, Zhao B, Liu F, Liu T, Duan Y, et al. Single-cell transcriptomic analysis of the immune microenvironment in pediatric acute leukemia. Cancer Lett. 2024;596:217018.","journal-title":"Cancer Lett"},{"issue":"19","key":"795_CR17","first-page":"e2101447","volume":"8","author":"X Wang","year":"2021","unstructured":"Wang X, Chen Y, Li Z, Huang B, Xu L, Lai J, et al. Single-Cell RNA-Seq of T cells in B-ALL patients reveals an exhausted subset with remarkable heterogeneity. Adv Sci (Weinheim Baden-Wurttemberg Germany). 2021;8(19):e2101447.","journal-title":"Adv Sci (Weinheim Baden-Wurttemberg Germany)"},{"issue":"5","key":"795_CR18","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler A, Hoffman P, Smibert P, Papalexi E, Satija R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol. 2018;36(5):411\u201320.","journal-title":"Nat Biotechnol"},{"issue":"12","key":"795_CR19","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, et al. Fast, sensitive and accurate integration of single-cell data with harmony. Nat Methods. 2019;16(12):1289\u201396.","journal-title":"Nat Methods"},{"issue":"12","key":"795_CR20","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1016\/j.immuni.2023.10.013","volume":"56","author":"M Terekhova","year":"2023","unstructured":"Terekhova M, Swain A, Bohacova P, Aladyeva E, Arthur L, Laha A, et al. Single-cell atlas of healthy human blood unveils age-related loss of NKG2C(+)GZMB(-)CD8(+) memory T cells and accumulation of type 2 memory T cells. Immunity. 2023;56(12):2836\u2013e549.","journal-title":"Immunity"},{"issue":"5","key":"795_CR21","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. ClusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137.","journal-title":"OMICS"},{"issue":"6","key":"795_CR22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsd\u00f3ttir H, Ghandi M, Mesirov JP, Tamayo P. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1(6):417\u201325.","journal-title":"Cell Syst"},{"key":"795_CR23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.","journal-title":"BMC Bioinformatics"},{"issue":"7","key":"795_CR24","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"795_CR25","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar S, Gonz\u00e1lez-Blas CB, Moerman T, Huynh-Thu VA, Imrichova H, Hulselmans G, et al. SCENIC: single-cell regulatory network inference and clustering. Nat Methods. 2017;14(11):1083\u20136.","journal-title":"Nat Methods"},{"issue":"3","key":"795_CR26","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nmeth.4150","volume":"14","author":"X Qiu","year":"2017","unstructured":"Qiu X, Hill A, Packer J, Lin D, Ma YA, Trapnell C. Single-cell mRNA quantification and differential analysis with census. Nat Methods. 2017;14(3):309\u201315.","journal-title":"Nat Methods"},{"issue":"1","key":"795_CR27","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.immuni.2018.12.021","volume":"50","author":"I Siddiqui","year":"2019","unstructured":"Siddiqui I, Schaeuble K, Chennupati V, Fuertes Marraco SA, Calderon-Copete S, Pais Ferreira D, et al. Intratumoral Tcf1(+)PD-1(+)CD8(+) T cells with Stem-like properties promote tumor control in response to vaccination and checkpoint Blockade immunotherapy. Immunity. 2019;50(1):195\u2013e21110.","journal-title":"Immunity"},{"key":"795_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1182\/blood-2021-149150","volume":"138","author":"F Mazziotta","year":"2021","unstructured":"Mazziotta F, Biavati L, Mukhopadhyay R, Knaus HA, Borrello IM, Gojo I, et al. Bone marrow GZMK\u2009<\u2009SUP>+\u2009IL7R\u2009<\u2009SUP>+\u2009Progenitor-Exhausted CD8\u2009<\u2009SUP>+\u2009T cells correlate with sustained clinical remission in patients with acute myeloid leukemia (AML) undergoing chemotherapy. Blood. 2021;138:3.","journal-title":"Blood"},{"issue":"5","key":"795_CR29","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1023\/A:1006676315093","volume":"20","author":"GR Brown","year":"2000","unstructured":"Brown GR, Thiele DL. T-cell activation and differentiation are regulated by TNF during murine DBA\/2\u2013>B6D2F1 intestinal graft-versus-host disease. J Clin Immunol. 2000;20(5):379\u201388.","journal-title":"J Clin Immunol"},{"key":"795_CR30","doi-asserted-by":"publisher","first-page":"967679","DOI":"10.3389\/fcimb.2022.967679","volume":"12","author":"L Tian","year":"2022","unstructured":"Tian L, Zhou W, Wu X, Hu Z, Qiu L, Zhang H, et al. CTLs: killers of intracellular bacteria. Front Cell Infect Microbiol. 2022;12:967679.","journal-title":"Front Cell Infect Microbiol"},{"key":"795_CR31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1182\/blood-2020-141249","volume":"136","author":"IM Michelozzi","year":"2020","unstructured":"Michelozzi IM, Gomez-Castaneda E, Pohle RVC, Rodriguez FC, Sufi J, Puigdevall P, et al. The enhanced functionality of Low-Affinity CD19 CAR T cells is associated with activation priming and polyfunctional cytokine phenotype. Blood. 2020;136:3.","journal-title":"Blood"},{"issue":"1","key":"795_CR32","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12943-023-01800-3","volume":"22","author":"X Chu","year":"2023","unstructured":"Chu X, Tian W, Wang Z, Zhang J, Zhou R. Co-inhibition of TIGIT and PD-1\/PD-L1 in Cancer immunotherapy: mechanisms and clinical trials. Mol Cancer. 2023;22(1):93.","journal-title":"Mol Cancer"},{"issue":"1","key":"795_CR33","doi-asserted-by":"publisher","first-page":"100004","DOI":"10.1016\/j.clnves.2024.100004","volume":"1","author":"P Wang","year":"2025","unstructured":"Wang P, Cai Q, Peng X, Dai Z, Liu J, Li W, et al. Increased co-expression of CTLA4\/LAG3 predicted adverse clinical outcomes in patients with T-cell malignancies. Cell Invest. 2025;1(1):100004.","journal-title":"Cell Invest"},{"issue":"3","key":"795_CR34","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/cmi.2016.55","volume":"14","author":"D Wu","year":"2017","unstructured":"Wu D, Wu P, Qiu F, Wei Q, Huang J. Human \u03b3\u03b4T-cell subsets and their involvement in tumor immunity. Cell Mol Immunol. 2017;14(3):245\u201353.","journal-title":"Cell Mol Immunol"},{"issue":"4","key":"795_CR35","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nri2526","volume":"9","author":"M Croft","year":"2009","unstructured":"Croft M. The role of TNF superfamily members in T-cell function and diseases. Nat Rev Immunol. 2009;9(4):271\u201385.","journal-title":"Nat Rev Immunol"},{"key":"795_CR36","doi-asserted-by":"crossref","unstructured":"Kearney CJ, Vervoort SJ, Hogg SJ, Ramsbottom KM, Freeman AJ, Lalaoui N et al. Tumor immune evasion arises through loss of TNF sensitivity. Sci Immunol. 2018;3(23).","DOI":"10.1126\/sciimmunol.aar3451"},{"issue":"14","key":"795_CR37","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1158\/1078-0432.CCR-23-0258","volume":"29","author":"M Heiduk","year":"2023","unstructured":"Heiduk M, Klimova A, Reiche C, Digomann D, Beer C, Aust DE, et al. TIGIT expression delineates T-cell populations with distinct functional and prognostic impact in pancreatic Cancer. Clin cancer Research: Official J Am Association Cancer Res. 2023;29(14):2638\u201350.","journal-title":"Clin cancer Research: Official J Am Association Cancer Res"},{"issue":"1","key":"795_CR38","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1080\/08820139.2020.1806868","volume":"51","author":"Z Jin","year":"2022","unstructured":"Jin Z, Lan T, Zhao Y, Du J, Chen J, Lai J, et al. Higher TIGIT(+)CD226(-) \u03b3\u03b4 T cells in patients with acute myeloid leukemia. Immunol Investig. 2022;51(1):40\u201350.","journal-title":"Immunol Investig"},{"key":"795_CR39","doi-asserted-by":"publisher","first-page":"216985","DOI":"10.1016\/j.canlet.2024.216985","volume":"595","author":"DJ Agorku","year":"2024","unstructured":"Agorku DJ, Bosio A, Alves F, Str\u00f6bel P, Hardt O. Colorectal cancer-associated fibroblasts inhibit effector T cells via NECTIN2 signaling. Cancer Lett. 2024;595:216985.","journal-title":"Cancer Lett"},{"issue":"1","key":"795_CR40","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40364-023-00543-z","volume":"12","author":"P Zhang","year":"2024","unstructured":"Zhang P, Liu X, Gu Z, Jiang Z, Zhao S, Song Y, et al. Targeting TIGIT for cancer immunotherapy: recent advances and future directions. Biomark Res. 2024;12(1):7.","journal-title":"Biomark Res"},{"issue":"10","key":"795_CR41","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.ccell.2021.07.007","volume":"39","author":"WA Freed-Pastor","year":"2021","unstructured":"Freed-Pastor WA, Lambert LJ, Ely ZA, Pattada NB, Bhutkar A, Eng G, et al. The CD155\/TIGIT axis promotes and maintains immune evasion in neoantigen-expressing pancreatic cancer. Cancer Cell. 2021;39(10):1342\u2013e6014.","journal-title":"Cancer Cell"},{"key":"795_CR42","doi-asserted-by":"crossref","unstructured":"Yeo J, Ko M, Lee DH, Park Y, Jin HS. TIGIT\/CD226 Axis regulates Anti-Tumor immunity. Pharmaceuticals (Basel Switzerland). 2021;14(3).","DOI":"10.3390\/ph14030200"},{"issue":"9","key":"795_CR43","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1093\/intimm\/11.9.1451","volume":"11","author":"C Abbal","year":"1999","unstructured":"Abbal C, Jourdan P, Hori T, Bousquet J, Yssel H, P\u00e8ne J. TCR-mediated activation of allergen-specific CD45RO(+) memory T lymphocytes results in down-regulation of cell-surface CXCR4 expression and a strongly reduced capacity to migrate in response to stromal cell-derived factor-1. Int Immunol. 1999;11(9):1451\u201362.","journal-title":"Int Immunol"},{"issue":"10","key":"795_CR44","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1002\/(SICI)1521-4141(199810)28:10<3192::AID-IMMU3192>3.0.CO;2-E","volume":"28","author":"M Bermejo","year":"1998","unstructured":"Bermejo M, Mart\u00edn-Serrano J, Oberlin E, Pedraza MA, Serrano A, Santiago B, et al. Activation of blood T lymphocytes down-regulates CXCR4 expression and interferes with propagation of X4 HIV strains. Eur J Immunol. 1998;28(10):3192\u2013204.","journal-title":"Eur J Immunol"},{"issue":"2","key":"795_CR45","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/immu.200310023","volume":"33","author":"A Langenkamp","year":"2003","unstructured":"Langenkamp A, Nagata K, Murphy K, Wu L, Lanzavecchia A, Sallusto F. Kinetics and expression patterns of chemokine receptors in human CD4\u2009+\u2009T lymphocytes primed by myeloid or plasmacytoid dendritic cells. Eur J Immunol. 2003;33(2):474\u201382.","journal-title":"Eur J Immunol"},{"issue":"6","key":"795_CR46","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1084\/jem.187.6.875","volume":"187","author":"F Sallusto","year":"1998","unstructured":"Sallusto F, Lenig D, Mackay CR, Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med. 1998;187(6):875\u201383.","journal-title":"J Exp Med"},{"issue":"21","key":"795_CR47","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1182\/blood.2023020050","volume":"141","author":"MY Kim","year":"2023","unstructured":"Kim MY. CXCR4 to improve both T cell homing and function. Blood. 2023;141(21):2546\u20137.","journal-title":"Blood"},{"key":"795_CR48","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40364-017-0083-x","volume":"5","author":"R de Necochea-Campion","year":"2017","unstructured":"de Necochea-Campion R, Zuckerman LM, Mirshahidi HR, Khosrowpour S, Chen CS, Mirshahidi S. Metastatic biomarkers in synovial sarcoma. Biomark Res. 2017;5:4.","journal-title":"Biomark Res"},{"issue":"6","key":"795_CR49","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.immuni.2016.10.018","volume":"45","author":"C Gerlach","year":"2016","unstructured":"Gerlach C, Moseman EA, Loughhead SM, Alvarez D, Zwijnenburg AJ, Waanders L, et al. The chemokine receptor CX3CR1 defines three Antigen-Experienced CD8 T cell subsets with distinct roles in immune surveillance and homeostasis. Immunity. 2016;45(6):1270\u201384.","journal-title":"Immunity"},{"key":"795_CR50","doi-asserted-by":"publisher","first-page":"8306","DOI":"10.1038\/ncomms9306","volume":"6","author":"JP B\u00f6ttcher","year":"2015","unstructured":"B\u00f6ttcher JP, Beyer M, Meissner F, Abdullah Z, Sander J, H\u00f6chst B, et al. Functional classification of memory CD8(+) T cells by CX3CR1 expression. Nat Commun. 2015;6:8306.","journal-title":"Nat Commun"},{"issue":"4","key":"795_CR51","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s11357-009-9100-9","volume":"31","author":"SM Henson","year":"2009","unstructured":"Henson SM, Akbar AN. KLRG1\u2013more than a marker for T cell senescence. Age (Dordrecht Netherlands). 2009;31(4):285\u201391.","journal-title":"Age (Dordrecht Netherlands)"},{"issue":"11","key":"795_CR52","doi-asserted-by":"publisher","first-page":"531","DOI":"10.4049\/immunohorizons.1900087","volume":"3","author":"M Motamedi","year":"2019","unstructured":"Motamedi M, Shahbaz S, Fu L, Dunsmore G, Xu L, Harrington R, et al. Galectin-9 expression defines a subpopulation of NK cells with impaired cytotoxic effector molecules but enhanced IFN-\u03b3 production, dichotomous to TIGIT, in HIV-1 infection. ImmunoHorizons. 2019;3(11):531\u201346.","journal-title":"ImmunoHorizons"},{"issue":"12","key":"795_CR53","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/s41571-022-00689-z","volume":"19","author":"A Chow","year":"2022","unstructured":"Chow A, Perica K, Klebanoff CA, Wolchok JD. Clinical implications of T cell exhaustion for cancer immunotherapy. Nat Reviews Clin Oncol. 2022;19(12):775\u201390.","journal-title":"Nat Reviews Clin Oncol"},{"issue":"1","key":"795_CR54","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1038\/s41467-021-23324-4","volume":"12","author":"M Andreatta","year":"2021","unstructured":"Andreatta M, Corria-Osorio J, M\u00fcller S, Cubas R, Coukos G, Carmona SJ. Interpretation of T cell States from single-cell transcriptomics data using reference atlases. Nat Commun. 2021;12(1):2965.","journal-title":"Nat Commun"},{"issue":"6","key":"795_CR55","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.cell.2023.02.021","volume":"186","author":"MK Rahim","year":"2023","unstructured":"Rahim MK, Okholm TLH, Jones KB, McCarthy EE, Liu CC, Yee JL, et al. Dynamic CD8(+) T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes. Cell. 2023;186(6):1127\u2013e4318.","journal-title":"Cell"},{"issue":"2","key":"795_CR56","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.immuni.2016.07.011","volume":"45","author":"A Schietinger","year":"2016","unstructured":"Schietinger A, Philip M, Krisnawan VE, Chiu EY, Delrow JJ, Basom RS, et al. Tumor-Specific T cell dysfunction is a dynamic Antigen-Driven differentiation program initiated early during tumorigenesis. Immunity. 2016;45(2):389\u2013401.","journal-title":"Immunity"},{"key":"795_CR57","doi-asserted-by":"crossref","unstructured":"Wu T, Ji Y, Moseman EA, Xu HC, Manglani M, Kirby M et al. The TCF1-Bcl6 axis counteracts type I interferon to repress exhaustion and maintain T cell stemness. Sci Immunol. 2016;1(6).","DOI":"10.1126\/sciimmunol.aai8593"},{"issue":"4","key":"795_CR58","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.immuni.2023.01.029","volume":"56","author":"AF Marx","year":"2023","unstructured":"Marx AF, Kallert SM, Brunner TM, Villegas JA, Geier F, Fixemer J, et al. The alarmin interleukin-33 promotes the expansion and preserves the stemness of Tcf-1(+) CD8(+) T cells in chronic viral infection. Immunity. 2023;56(4):813\u2013e2810.","journal-title":"Immunity"},{"issue":"12","key":"795_CR59","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1016\/j.immuni.2022.10.020","volume":"55","author":"S Lukhele","year":"2022","unstructured":"Lukhele S, Rabbo DA, Guo M, Shen J, Elsaesser HJ, Quevedo R, et al. The transcription factor IRF2 drives interferon-mediated CD8(+) T cell exhaustion to restrict anti-tumor immunity. Immunity. 2022;55(12):2369\u2013e8510.","journal-title":"Immunity"},{"issue":"7990","key":"795_CR60","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41586-023-06733-x","volume":"624","author":"P Zhou","year":"2023","unstructured":"Zhou P, Shi H, Huang H, Sun X, Yuan S, Chapman NM, et al. Single-cell CRISPR screens in vivo map T cell fate regulomes in cancer. Nature. 2023;624(7990):154\u201363.","journal-title":"Nature"},{"issue":"7","key":"795_CR61","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1182\/bloodadvances.2021006367","volume":"6","author":"T Shahin","year":"2022","unstructured":"Shahin T, Mayr D, Shoeb MR, Kuehn HS, Hoeger B, Giuliani S, et al. Identification of germline monoallelic mutations in IKZF2 in patients with immune dysregulation. Blood Adv. 2022;6(7):2444\u201351.","journal-title":"Blood Adv"},{"key":"795_CR62","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.3389\/fimmu.2018.02981","volume":"9","author":"J Li","year":"2018","unstructured":"Li J, He Y, Hao J, Ni L, Dong C. High levels of Eomes promote exhaustion of Anti-tumor CD8(+) T cells. Front Immunol. 2018;9:2981.","journal-title":"Front Immunol"},{"issue":"6","key":"795_CR63","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.immuni.2019.11.002","volume":"51","author":"WH Hudson","year":"2019","unstructured":"Hudson WH, Gensheimer J, Hashimoto M, Wieland A, Valanparambil RM, Li P, et al. Proliferating transitory T cells with an Effector-like transcriptional signature emerge from PD-1(+) Stem-like CD8(+) T cells during chronic infection. Immunity. 2019;51(6):1043\u2013e584.","journal-title":"Immunity"},{"issue":"6","key":"795_CR64","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.immuni.2019.10.009","volume":"51","author":"R Zander","year":"2019","unstructured":"Zander R, Schauder D, Xin G, Nguyen C, Wu X, Zajac A, et al. CD4(+) T cell help is required for the formation of a cytolytic CD8(+) T cell subset that protects against chronic infection and Cancer. Immunity. 2019;51(6):1028\u2013e424.","journal-title":"Immunity"},{"key":"795_CR65","doi-asserted-by":"crossref","unstructured":"Duurland CL, Santegoets SJ, Abdulrahman Z, Loof NM, Sturm G, Wesselink TH et al. CD161 expression and regulation defines rapidly responding effector CD4\u2009+\u2009T cells associated with improved survival in HPV16-associated tumors. J Immunother Cancer. 2022;10(1).","DOI":"10.1136\/jitc-2021-003995"}],"container-title":["Biomarker Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-025-00795-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40364-025-00795-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-025-00795-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T18:03:05Z","timestamp":1749319385000},"score":1,"resource":{"primary":{"URL":"https:\/\/biomarkerres.biomedcentral.com\/articles\/10.1186\/s40364-025-00795-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,7]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["795"],"URL":"https:\/\/doi.org\/10.1186\/s40364-025-00795-x","relation":{},"ISSN":["2050-7771"],"issn-type":[{"value":"2050-7771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,7]]},"assertion":[{"value":"11 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and written informed consent was obtained from all patients before inclusion in the study. The study protocol was approved by the Ethics Committee of the Medical School of Jinan University (JNUKY-2023-0104) and followed the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"82"}}